Home/Filings/4/0000313143-13-000152
4//SEC Filing

HAEMONETICS CORP 4

Accession 0000313143-13-000152

$HAECIK 0000313143operating

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 5:08 PM ET

Size

10.8 KB

Accession

0000313143-13-000152

Insider Transaction Report

Form 4
Period: 2013-07-30
Kelly Michael P
President, NA, Global Plasma
Transactions
  • Disposition to Issuer

    Common Stock

    2013-07-30$40.67/sh399$16,22811,337 total
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $39.05From: 2013-10-24Exp: 2019-10-24Common Stock (39,344 underlying)
    39,344
  • Non-Qualified Stock Option (right to buy)

    Exercise: $27.48From: 2011-07-28Exp: 2017-07-28Common Stock (52,740 underlying)
    52,740
  • Non-Qualified Stock Option (right to buy)

    Exercise: $30.67From: 2012-10-25Exp: 2018-10-25Common Stock (37,326 underlying)
    37,326
  • Performance Shares

    Exercise: $0.00From: 2027-03-31Exp: 2017-12-31Common Stock (25,000 underlying)
    25,000
Footnotes (4)
  • [F1]Pursuant to a 10b5-1 Plan.
  • [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  • [F4]Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000313143

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:08 PM ET
Size
10.8 KB